Stock

Citadel’s Ken Griffin buys a stegosaurus for $45 million in a record auction sale

Billionaire investor Ken Griffin, founder and CEO of hedge fund Citadel, purchased a late-Jurassic stegosaurus skeleton for $44.6 million at Sotheby’s Wednesday, marking the most valuable fossil ever sold at auction.

The 150 million-year-old stegosaurus named “Apex” measures 11 feet tall and nearly 27 feet long from nose to tail and it is a nearly complete skeleton with 254 fossil bone elements. Apex was only expected to sell for about $6 million.

Griffin won the live auction in New York Wednesday after competing with six other bidders for 15 minutes. He intends to explore loaning the specimen to a U.S. institution, according to people familiar with his plans.

“Apex was born in America and is going to stay in America!” Griffin said after the sale.

Apex shows no signs of combat-related injuries or evidence of post-mortem scavenging, Sotheby’s said. The stegosaurus was excavated on private land in Moffat County, Colorado.

In 2018, Griffin gifted $16.5 million to Chicago’s Field Museum to help fund the display of a touchable cast of the biggest dinosaur ever discovered — a giant, long-necked herbivore from Argentina.

In 2021, he paid $43.2 million for a first-edition copy of the U.S. Constitution, outbidding a group of cryptocurrency investors. He later loaned it to the Crystal Bridges Museum of American Art in Arkansas.

This post appeared first on NBC NEWS

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version